SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-019389
Filing Date
2022-02-10
Accepted
2022-02-10 16:19:31
Documents
2
Group Members
COUGAR INVESTMENT HOLDINGS LLCVC CAPITAL HOLDINGS COLUMBIA LLCVCHC MANAGEMENT LLCVCVC MANAGEMENT V LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm226107d1_sc13g.htm SC 13G 116864
2 EXHIBIT 99.1 tm226107d1_ex99-1.htm EX-99.1 9828
  Complete submission text file 0001104659-22-019389.txt   128388
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Subject) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91615 | Film No.: 22614219
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 505 FIFTH AVENUE SOUTH SUITE 900 SEATTLE WA 98104
Business Address 505 FIFTH AVENUE SOUTH SUITE 900 SEATTLE WA 98104 425-225-7140
VCVC V LLC (Filed by) CIK: 0001909790 (see all company filings)

IRS No.: 000000000
Type: SC 13G